Clinical Trials
11 trialsNCT02173756 2026-03-16
MorphinOgel
University Hospital, Strasbourg, France
Phase 3 Terminated
NCT05315908 2024-02-28
COVID-19 Testing in Underserved and Vulnerable Populations
University of California, San Diego
Phase NA Terminated
NCT03297359 2024-01-23
WAVe
Ottawa Hospital Research Institute
Phase 2 Terminated
NCT04097353 2023-03-13
Improving Health Behaviors for Pediatric Cancer Survivors
Nationwide Children's Hospital
Phase NA Terminated
NCT02745353 2019-12-09
Naloxegol in Cancer Opioid-Induced Constipation
University of California, San Diego
Phase 2 Terminated
NCT01189409 2019-08-28
Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients
British Columbia Cancer Agency
Phase 4 Terminated
NCT02300727 2019-05-31
Study to See How Safe Curcumin is and How Well it Works When Used to Treat Mucositis in Patients Getting Chemotherapy
Aurora BayCare Medical Center
Phase 1/2 Terminated
NCT02839889 2019-03-05
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
Hospice of Henderson County, Inc.
Phase 4 Terminated
NCT02606994 2019-02-06
TPvsM
Oral Defense, LLC
Phase 2 Terminated
NCT00331045 2015-09-02
Clinical Evaluation Of Alvimopan (SB767905) On Constipation And Related Symptoms Associated With Opioid
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2 Terminated
NCT00224692 2006-10-26
Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With Morphine
Assistance Publique - Hôpitaux de Paris
Phase 3 Terminated